Literature DB >> 26109228

Prehospital stroke care: telemedicine, thrombolysis and neuroprotection.

Joachim Weber1, Martin Ebinger, Heinrich J Audebert.   

Abstract

Over the last 15 years, new approaches regarding neuroprotective and thrombolytic strategies in stroke management have been evaluated in the prehospital setting. These efforts have provided exciting new potentials of hyperacute stroke care. Trials have shown that the use of specialized stroke ambulances increases the proportion of patients receiving intravenous thrombolysis and shortens alarm-to-treatment time by approximately half an hour compared to standard care. Intravenous thrombolysis within the ultra-early time window of the 'golden hour' has become a realistic scenario. However, direct effects of prehospital stroke care on functional outcome have yet to be shown and other approaches such as neuroprotective treatments could not demonstrate clinical benefit so far. There is a clear need for systematic research in the prehospital field to test the clinical effectiveness and cost-effectiveness of new therapeutic strategies. It will be necessary to test various components of prehospital stroke care alone and in combination.

Entities:  

Keywords:  endovascular treatment; hemorrhagic stroke; ischemic stroke; neuroprotection; prehospital stroke care; stroke ambulance; thrombolysis

Mesh:

Year:  2015        PMID: 26109228     DOI: 10.1586/14737175.2015.1051967

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

1.  Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Pavla Kadlecová; Anna Czlonkowska; Adam Kobayashi; Miroslav Brozman; Viktor Švigelj; Laszlo Csiba; Klara Fekete; Janika Kõrv; Vida Demarin; Aleksandras Vilionskis; Dalius Jatuzis; Yakup Krespi; Chrissoula Liantinioti; Sotirios Giannopoulos; Robert Mikulik
Journal:  J Neurol       Date:  2017-03-18       Impact factor: 4.849

2.  Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies.

Authors:  Simone Beretta; Alessandro Versace; Davide Carone; Matteo Riva; Valentina Dell'Era; Elisa Cuccione; Ruiyao Cai; Laura Monza; Silvia Pirovano; Giada Padovano; Fabio Stiro; Luca Presotto; Giovanni Paternò; Emanuela Rossi; Carlo Giussani; Erik P Sganzerla; Carlo Ferrarese
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-23       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.